Dr. Acampora is a Consultant in Radiology and a Specialist in Healthy Aging Medicine, both from the inside out. She is the leading expert in Personalised Bioidentical Hormone Replacement Therapy in the aging population, for the treatment of symptoms of menopause and andropause, both in the UK and in Italy. She completed Medical School in Italy where she achieved the maximum score possible with ‘summa cum laude’ ratings in not only her medical degree, but also her Radiology specialist training. She was inspired by the latest advances in the science of healthy longevity and technology and, together with a team of leading entrepreneurs and scientists, she decided to combine the two into Harmon.

Leo holds a B.A. in Economics from the University of Virginia. He began his experience as an Associate Auditor at Baker Tilly where he led teams for due diligence processes, yearly audits, IPO audits, and various risk assessment projects with varied sector focus in Technology, Retail, Healthcare and Textiles. After Baker Tilly, Leo moved on to restructure various companies. He then moved on to join Orbital Technology as Chief Strategy Officer to aid in their global expansion where he brought revenues from a standstill to six figures MRR. Leo is excited to work with Harmon because of its innovative and empowering program that enables people to thrive as they age.

Maurice, the Chief Technology Officer at Harmon, boasts over two decades of influential experience in technology and leadership, holding pivotal roles in esteemed organizations such as Juvenescence Life, The Vitamin Shoppe, Hudson’s Bay Company, and Saks Fifth Avenue. With a degree in Information Management and Technology from Syracuse University, he's been at the forefront of renowned organizations, driving all-channel goals, championing omni-channel programs, and agile methodologies, delivering the experiences that customer want. Maurice possesses a diverse skill set and a passion for the potential of technology in healthcare. Harmon's unwavering dedication to pioneering a brighter future in healthcare and aging aligns seamlessly with Maurice's commitment and expertise. He is excited to join Harmon as CTO, driven by shared dedication to enhancing lives through technological innovation and personalized care.

Ahmet Soybelli is a seasoned marketing professional specializing in B2B SaaS, digital analytics, and lead-generation. With a proven track record of guiding startups to success, he's adept at crafting timely marketing strategies aligned with the latest digital trends. Not just a strategist, Ahmet is a team leader skilled in PPC, Google Analytics, and formulating growth strategies for emerging businesses. He particularly enjoys working with innovators like Harmon, as he values the fusion of healthcare and technological innovation to improve people lives. Ahmet's blend of theoretical and hands-on expertise positions him as a trusted figure in the digital marketing and startup realms.

Dionne Simons began her career in healthcare over 15 years ago, gaining invaluable experience and expertise in the field. Dionne has a bachelor’s degree in business, she’s CIPD qualified and have completed multiple certifications in Healthcare Management, ensuring that she stays up to date with the latest advancements in the field. She provides a supportive environment where patients feel heard, valued, and empowered. She works closely with the doctors and patients to ensure exceptional standards of care. Dionne is devoted to support Harmon’s members in their journey to achieve optimal health and well-being through personalized care and on-going support.

Dr. Greg Bailey, MD, is a physician, financier, and biotech entrepreneur with extensive experience founding and financing healthcare companies. Dr. Bailey sits on Harmon’s board. Dr. Bailey was a former managing partner of Palantir Group, Inc., a merchant bank specializing in biotech and intellectual property and he was the initial financier and an independent director of Medivation, Inc. (MDVN:NASDAQ), acquired by Pfizer in 2016. He also led the seed financing of Biohaven Pharmaceuticals Holding Company Ltd. and joined the board in 2014.Previously, he founded or financed Ascent Healthcare Solutions, VirnetX Inc. (VHC:AMEX), and SalvaRx Group PLC. He is also a board member of AgeX Therapeutics.Dr. Baily is the co-founder and executive charmain at Juvenescence, a pioneering company that focus on the discovery of disruptive pharmaceuticals that slow, halt or reverse aging.

Denham Eke sits on Harmon's board, having 25+ years' experience in directorship roles of large organizations where he has been tasked with rationalizing and restructuring operations to enhance profitability.

Dr. Acampora is a Consultant in Radiology and a Specialist in Healthy Aging Medicine, both from the inside out. She is the leading expert in Personalised Bioidentical Hormone Replacement Therapy in the aging population, for the treatment of symptoms of menopause and andropause, both in the UK and in Italy. She completed Medical School in Italy where she achieved the maximum score possible with ‘summa cum laude’ ratings in not only her medical degree, but also her Radiology specialist training. She was inspired by the latest advances in the science of healthy longevity and technology and, together with a team of leading entrepreneurs and scientists, she decided to combine the two into Harmon.